Log in to your Inderes Free account to see all free content on this page.
Nanoform Finland
0.50 EUR
+4.63 %
3,710 following
NANOFH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Nanoform Finland
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.5 | 6.9 | 20.0 | 39.0 | 28.6 | 31.9 | 38.3 |
| growth-% | 1,250.7 % | 188.9 % | 94.7 % | -26.6 % | 11.4 % | 20.4 % | |
| EBITDA | -72.3 | -183.6 | -181.9 | -212.5 | -218.2 | -241.0 | -164.6 |
| EBIT | -76.9 | -196.0 | -202.0 | -239.2 | -250.3 | -278.0 | -199.6 |
| Profit before taxes | -79.1 | -196.1 | -201.8 | -246.4 | -230.8 | -268.4 | -193.0 |
| Net income | -79.1 | -196.2 | -201.8 | -246.6 | -231.1 | -268.7 | -193.4 |
| EPS | -1.19 | -2.95 | -3.03 | -3.24 | -2.89 | -3.21 | -2.27 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -14,081.6 % | -2,648.8 % | -908.1 % | -545.2 % | -762.6 % | -756.5 % | -429.3 % |
| EBIT-% | -14,987.8 % | -2,827.2 % | -1,008.4 % | -613.5 % | -874.7 % | -872.4 % | -520.6 % |
| ROE | -95.2 % | -31.0 % | -23.3 % | -25.3 % | -31.0 % | -39.0 % | -41.8 % |
| ROI | -58.5 % | -26.3 % | -19.8 % | -21.9 % | -26.6 % | -32.6 % | -33.2 % |
Login required
This content is only available for logged in users